Tanaka H et al. |
Leukotriene (LT)-receptor antagonist is more effective in asthmatic patients with a low baseline ratio of urinary LTE4 to 2,3-dinor-6-keto-prostaglandin (PG)F1alpha. |
1999 |
Allergy |
pmid:10380781
|
Elissalde MH and Beier RC |
Stimulation and release of prostaglandins and thromboxane from macrophages by cotton dust associated lipopolysaccharides. |
1990 |
Am Ind Hyg Assoc J |
pmid:2270833
|
Andersson T et al. |
Evaluation of the pharmacodynamics of acetylsalicylic acid 81 mg with or without esomeprazole 20 mg in healthy volunteers. |
2012 |
Am J Cardiovasc Drugs |
pmid:22631032
|
Leese PT et al. |
Valdecoxib does not impair platelet function. |
2002 |
Am J Emerg Med |
pmid:12098171
|
Jung TT and Juhn SK |
Prostaglandins in human cholesteatoma and granulation tissue. |
1988 |
Am J Otol |
pmid:3177602
|
Mehta P et al. |
Plasma concentrations of thromboxane and prostacyclin metabolites in patients with bone tumors. |
1985 |
Am J Pediatr Hematol Oncol |
pmid:2994511
|
Natarajan G et al. |
Chorioamnionitis and ontogeny of circulating prostaglandin and thromboxane in preterm infants. |
2008 |
Am J Perinatol |
pmid:18726836
|
Brown HL et al. |
Plasma and amniotic fluid prostacyclin and thromboxane in mild pregnancy-induced hypertension. |
1987 |
Am J Perinatol |
pmid:3566883
|
Satterfield S et al. |
Biochemical markers of compliance in the Physicians' Health Study. |
1990 Sep-Oct |
Am J Prev Med |
pmid:2268456
|
Ingster LM and Feinleib M |
Salicylate intake and cardiovascular disease: Ingster and Feinleib respond to Hu and Willett. |
1998 |
Am J Public Health |
pmid:9702172
|
Cambria RA et al. |
Thromboxane synthetase inhibition decreases polymorphonuclear leukocyte activation following hindlimb ischemia. |
1991 |
Am Surg |
pmid:1847027
|
Smith EF and Lefer AM |
Stabilization of cardiac lysosomal and cellular membranes in protection of ischemic myocardium due to coronary occlusion:efficacy of the nonsteroidal anti-inflammatory agent, naproxen. |
1981 |
Am. Heart J. |
pmid:7211667
|
Nakashima Y et al. |
Sustained-release nifedipine (nifedipine-L) suppresses plasma thromboxane B2 and 6-keto prostaglandin F1 alpha in both young male smokers and nonsmokers. |
1990 |
Am. Heart J. |
pmid:2353613
|
Nitz RE and Martorana PA |
The activity of molsidomine in experimental models of ischemic cardiac disease. |
1985 |
Am. Heart J. |
pmid:3919549
|
Walinsky P et al. |
Thromboxane A2 in acute myocardial infarction. |
1984 |
Am. Heart J. |
pmid:6485997
|
Buerke M et al. |
Aspirin therapy: optimized platelet inhibition with different loading and maintenance doses. |
1995 |
Am. Heart J. |
pmid:7661062
|
De Servi S et al. |
Coronary vasoconstrictor response to cold pressor test in variant angina: lack of relation to intracoronary thromboxane concentrations. |
1987 |
Am. Heart J. |
pmid:3630891
|
Cotter G et al. |
Lack of aspirin effect: aspirin resistance or resistance to taking aspirin? |
2004 |
Am. Heart J. |
pmid:14760328
|
Arora RR et al. |
Laser-induced stimulation of thromboxane B2 synthesis in human blood platelets: role of superoxide radicals. |
1993 |
Am. Heart J. |
pmid:8381256
|
Jouve R et al. |
Thromboxane B2, 6-keto-PGF1 alpha, PGE2, PGF2 alpha, and PGA1 plasma levels in arteriosclerosis obliterans: relationship to clinical manifestations, risk factors, and arterial pathoanatomy. |
1984 |
Am. Heart J. |
pmid:6581715
|